Prevalence of mucosal and cutaneous human papillomaviruses in different histologic subtypes of vulvar carcinoma

Modern Pathology

Volumn 21, Issue 3, 2008, Pages 334-344

  De Koning, Maurits N C ^a   Quint, Wim G V ^a   Pirog, Edyta C ^b  

^a DDL DIAGNOSTIC LABORATORY   (Netherlands)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

HPV; P16INK4a; Vulvar carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; PRIORITY JOURNAL; VIRUS DETECTION; VULVA CARCINOMA; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CARCINOMA, VERRUCOUS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MUCOUS MEMBRANE; ONCOGENE PROTEINS, VIRAL; ORGAN SPECIFICITY; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; REPRESSOR PROTEINS; SKIN; TUMOR VIRUS INFECTIONS; VULVAR NEOPLASMS;

EID: 39749181497     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3801009     Document Type: Article

References (58)

1. Wilkinson EJ. Premalignant and malignant tumors of the vulva. In: Kurman RJ (ed). Blaustein's Pathology of the Female Genital Tract, 5th edn. Springer: New York, 2002, pp 99-122.
2. Crum CP. Carcinoma of the vulva: epidemiology and pathogenesis. Obstet Gynecol 1992;79:448-454.
3. Andersen WA, Franquemont DW, Williams J, et al. Vulvar squamous cell carcinoma and papillomaviruses: two separate entities? Am J Obstet Gynecol 1991;165:329-335.
4. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991;10:107-125.
5. Nuovo GJ, Delvenne P, MacConnell P, et al. Correlation of histology and detection of human papillomavirus DNA in vulvar cancers. Gynecol Oncol 1991;43:275-280.
6. Bloss JD, Liao SY, Wilczynski SP, et al. Clinical and histologic features of vulvar carcinomas analyzed for human papillomavirus status: evidence that squamous cell carcinoma of the vulva has more than one etiology. Hum Pathol 1991;22:711-718.
7. Kurman RJ, Toki T, Schiffman MH. Basaloid and warty carcinomas of the vulva. Distinctive types of squamous cell carcinoma frequently associated with human papillomaviruses. Am J Surg Pathol 1993;17:133-145.
8. Hording U, Kringsholm B, Andreasson B, et al. Human papillomavirus in vulvar squamous-cell carcinoma and in normal vulvar tissues: a search for a possible impact of HPV on vulvar cancer prognosis. Int J Cancer 1993;55:394-396.
9. Iwasawa A, Nieminen P, Lehtinen M, et al. Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction. Obstet Gynecol 1997;89:81-84.
10. Kagie MJ, Kenter GG, Zomerdijk-Nooijen Y, et al. Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin. Gynecol Oncol 1997;67:178-183.
11. Lee YY, Wilczynski SP, Chumakov A, et al. Carcinoma of the vulva: HPV and p53 mutations. Oncogene 1994;9:1655-1659.
12. Pinto AP, Signorello LB, Crum CP, et al. Squamous cell carcinoma of the vulva in Brazil: prognostic importance of host and viral variables. Gynecol Oncol 1999;74:61-67.
13. Santos M, Landolfi S, Olivella A, et al. p16 overexpression identifies HPV-positive vulvar squamous cell carcinomas. Am J Surg Pathol 2006;30:1347-1356.
14. Carlson JA, Ambros R, Malfetano J, et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. Hum Pathol 1998;29:932-948.
15. Kim YT, Thomas NF, Kessis TD, et al. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas. Hum Pathol 1996;27:389-395.
16. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30.
17. Yang B, Hart WR. Vulvar intraepithelial neoplasia of the simplex (differentiated) type: a clinicopathologic study including analysis of HPV and p53 expression. Am J Surg Pathol 2000;24:429-441.
18. Pinto AP, Lin MC, Sheets EE, et al. Allelic imbalance in lichen sclerosus, hyperplasia, and intraepithelial neoplasia of the vulva. Gynecol Oncol 2000;77:171-176.
19. Vanin K, Scurry J, Thorne H, et al. Overexpression of wild-type p53 in lichen sclerosus adjacent to human papillomavirus-negative vulvar cancer. J Invest Dermatol 2002;119:1027-1033.
20. Ngan HY, Cheung AN, Liu SS, et al. Abnormal expression or mutation of TP53 and HPV in vulvar cancer. Eur J Cancer 1999;35:481-484.
21. Nindl I, Gottschling M, Stockfleth E. Human papillomaviruses and non-melanoma skin cancer: Basic virology and clinical manifestations. Dis Markers 2007;23:247-259.
22. Pfister H. Chapter 8: Human papillomavirus and skin cancer. J Natl Cancer Inst Monogr 2003;31:52-56.
23. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000;61:289-297.
24. Stockfleth E, Nindl I, Sterry W, et al. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004;30:604-609.
25. Forslund O, Lindelof B, Hradil E, et al. High prevalence of cutaneous human papillomavirus DNA on the top of skin tumors but not in 'Stripped' biopsies from the same tumors. J Invest Dermatol 2004;123:388-394.
26. Antonsson A, Karanfilovska S, Lindqvist PG, et al. General acquisition of human papillomavirus infections of skin occurs in early infancy. J Clin Microbiol 2003;41:2509-2514.
27. Hazard K, Karlsson A, Andersson K, et al. Cutaneous human papillomaviruses persist on healthy skin. J Invest Dermatol 2007;127:116-119.
28. de Koning MNC, Struijk L, Bouwes Bavinck JN, et al. Betapapillomaviruses frequently persist in the skin of healthy individuals. J Gen Virol 2007;88:1489-1495.
29. Kohler A, Forschner T, Meyer T, et al. Multifocal distribution of cutaneous human papillomavirus types in hairs from different skin areas. Br J Dermatol 2007;156:1078-1080.
30. Boxman IL, Berkhout RJ, Mulder LH, et al. Detection of human papillomavirus DNA in plucked hairs from renal transplant recipients and healthy volunteers. J Invest Dermatol 1997;108:712-715.
31. Djurdjevic S, Devaja O, Hadzic B. Malignant potential of gigantic condylomatous lesions of the vulva. Eur J Gynaecol Oncol 1999;20:63-66.
32. Kondi-Paphitis A, Deligeorgi-Politi H, Liapis A, et al. Human papilloma virus in verrucus carcinoma of the vulva: an immunopathological study of three cases. Eur J Gynaecol Oncol 1998;19:319-320.
33. de Koning M, Quint W, Struijk L, et al. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J Clin Microbiol 2006;44:1792-1800.
34. Kleter B, van Doorn LJ, Ter SJ, et al. Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses. Am J Pathol 1998;153:1731-1739.
35. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-2517.
36. Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 1996;93:4350-4354.
37. Serrano M. The tumor suppressor protein p16INK4a. Exp Cell Res 1997;237:7-13.
38. Riethdorf S, Neffen EF, Cviko A, et al. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias. Hum Pathol 2004;35:1477-1483.
39. Giannoudis A, Herrington CS. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001;193:295-302.
40. Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006;118:1071-1076.
41. Yamada T, Wheeler CM, Halpern AL, et al. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol 1995;69:7743-7753.
42. van Doorn LJ, Molijn A, Kleter B, et al. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 2006;44:3292-3298.
43. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81:2959-2968.
44. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-1330.
45. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 1997;71:2463-2472.
46. Tornesello ML, Duraturo ML, Salatiello I, et al. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer. J Med Virol 2004;74:117-126.
47. Nascimento AF, Granter SR, Cviko A, et al. Vulvar acanthosis with altered differentiation: a precursor to verrucous carcinoma? Am J Surg Pathol 2004;28:638-643.
48. Gualco M, Bonin S, Foglia G, et al. Morphologic and biologic studies on ten cases of verrucous carcinoma of the vulva supporting the theory of a discrete clinicopathologic entity. Int J Gynecol Cancer 2003;13:317-324.
49. Masih AS, Stoler MH, Farrow GM, et al. Penile verrucous carcinoma: a clinicopathologic, human papillomavirus typing and flow cytometric analysis. Mod Pathol 1992;5:48-55.
50. Noel JC, Vandenbossche M, Peny MO, et al. Verrucous carcinoma of the penis: importance of human papillomavirus typing for diagnosis and therapeutic decision. Eur Urol 1992;22:83-85.
51. Pirog EC, Chen YT, Isacson C. MIB-1 immunostaining is a beneficial adjunct test for accurate diagnosis of vulvar condyloma acuminatum. Am J Surg Pathol 2000;24:1393-1399.
52. Bogomoletz WV, Potet F, Molas G. Condylomata acuminata, giant condyloma acuminatum (Buschke-Loewenstein tumour) and verrucous squamous carcinoma of the perianal and anorectal region: a continuous precancerous spectrum? Histopathology 1985;9:155-169.
53. Trombetta LJ, Place RJ. Giant condyloma acuminatum of the anorectum: trends in epidemiology and management: report of a case and review of the literature. Dis Colon Rectum 2001;44:1878-1886.
54. Chiesa-Vottero A, Dvoretsky PM, Hart WR. Histopathologic study of thin vulvar squamous cell carcinomas and associated cutaneous lesions: a correlative study of 48 tumors in 44 patients with analysis of adjacent vulvar intraepithelial neoplasia types and lichen sclerosus. Am J Surg Pathol 2006;30:310-318.
55. Iaconis L, Hyjek E, Ellenson LH, et al. p16 and Ki-67 immunostaining in atypical immature squamous metaplasia of the uterine cervix: correlation with human papillomavirus detection. Arch Pathol Lab Med 2007;131:1343-1349.
56. Liegl B, Regauer S. P53 immunostaining in lichen sclerosus is related to ischaemic stress and is not a marker of differentiated vulvar intraepithelial neoplasia (d-VIN). Histopathology 2006;48:268-274.
57. Chulvis do Val IC, Almeida Filho GL, Valiante PM, et al. Vulvar intraepithelial neoplasia p53 expression, p53 gene mutation and HPV in recurrent/progressive cases. J Reprod Med 2004;49:868-874.
58. Rolfe KJ, MacLean AB, Crow JC, et al. TP53 mutations in vulval lichen sclerosus adjacent to squamous cell carcinoma of the vulva. Br J Cancer 2003;89:2249-2253.